Spots Global Cancer Trial Database for germ cell cancer
Every month we try and update this database with for germ cell cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Music Therapy For The Treatment Of Cisplatin Induced Tinnitus In Patients With rGCC: A Pilot Study | NCT04402593 | Relapsed Germ C... Cisplatin Induc... | Modified Heidel... | 18 Years - | Indiana University | |
Brentuximab Vedotin (SGN-35) as Salvage Treatment for CD30-positive Germ Cell Tumors | NCT01851200 | Germ Cell Cance... | Brentuximab Ved... | 18 Years - | Fondazione Michelangelo | |
Toxicity Attributed to Genetic Polymorphisms in Testicular Germ Cell Tumor Survivors | NCT02303015 | Germ Cell Cance... | 15 Years - | Rigshospitalet, Denmark | ||
Study of Oxaliplatin Plus Bevacizumab in Germ Cell Tumor Patients | NCT00393861 | Neoplasms, Germ... | Bevacizumab and... | 18 Years - | Indiana University | |
Toxicity Attributed to Genetic Polymorphisms in Testicular Germ Cell Tumor Survivors | NCT02303015 | Germ Cell Cance... | 15 Years - | Rigshospitalet, Denmark | ||
Phase-II Study of SU011248 (Sunitinib)in Male Patients With Relapsed or Cisplatin-Refractory Germ Cell Cancer | NCT00371553 | Relapsed or Cis... | SU011248 (Sunit... | 18 Years - | British Columbia Cancer Agency | |
SerUm and Plasma MicroRNAs in Malignant Ovarian gERm Cell Tumours | NCT06329323 | Germ Cell Ovari... Germ Cell Tumor Germ Cell Cance... Germ Cell Neopl... Ovary Cancer Ovary Neoplasm Ovarian Cancer Ovarian Neoplas... | Blood test Pathology speci... | 16 Years - | Imperial College London | |
Everolimus for Patients With Relapsed/Refractory Germ Cell Cancer | NCT01242631 | Testicular Canc... Germ Cell Cance... | Everolimus | 18 Years - | Hannover Medical School | |
Genomic Structural Variation in Cancer Susceptibility | NCT00996710 | Breast Cancer Colon Cancer Germ Cell Cance... Neuroblastoma Rectal Cancer Sarcoma | - | Memorial Sloan Kettering Cancer Center | ||
Effectiveness of an Individualized Program of Muscular Strength and Endurance Program for Improving Germ Cell Cancer | NCT02433197 | Testicular Germ... | Aerobic program | 18 Years - 45 Years | University of Malaga | |
B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR) | NCT04897321 | Pediatric Solid... Osteosarcoma Rhabdomyosarcom... Neuroblastoma Ewing Sarcoma Wilms Tumor Adrenocortical ... Desmoplastic Sm... Germ Cell Cance... Rhabdoid Tumor Clear Cell Sarc... Hepatoblastoma Melanoma Carcinoma Malignant Perip... Soft Tissue Sar... | Fludarabine Cyclophosphamid... MESNA B7-H3 CAR T cel... | - 21 Years | St. Jude Children's Research Hospital | |
Sorafenib Monotherapy in Inoperable/Recurrent Germ Cell Carcinoma Refractory to Chemotherapy | NCT00772694 | Testicular Canc... | sorafenib | 18 Years - 75 Years | Fondation Wygrajmy Zdrowie | |
Acute Changes in Endothelial Function in Germ Cell Tumor Patients Treated With Cisplatin and Untreated Germ Cell Tumor Controls | NCT01453660 | Germ Cell Cance... | Endo-PAT2000 te... Endo-PAT2000 te... | 18 Years - | Memorial Sloan Kettering Cancer Center |